Journal of Microbiology and Biotechnology

The Korean Society for Microbiology and Biotechnology (한국미생물·생명공학회)
권호 표지
DOI QR코드

DOI QR Code

Downregulation of Hepatic De Novo Lipogenesis and Adipogenesis in Adipocytes by Pinus densiflora Bark Extract

  • Received : 2017.07.13
  • Accepted : 2017.09.04
  • Published : 2017.11.28
Download PDF
⟨ Previous Next ⟩

Abstract

Korean red pine (Pinus densiflora) bark extract, PineXol (PX), was investigated for its potential antioxidant and anti-inflammation effects in vitro. It was hypothesized that PX treatment ($25-150{\mu}g/ml$) would reduce the lipid synthesis in HepG2 hepatocytes as well as lipid accumulation in 3T3-L1 adipocytes. Hepatocytes' intracellular triglycerides and cholesterol were decreased in the PX $150{\mu}g/ml$ treatment group compared with the control (p < 0.05). Consequently, de novo lipogenic proteins (acetyl-CoA carboxylase 1, stearoyl-CoA desaturase 1, elongase of very long chain fatty acids 6, glycerol-3-phosphate acyltransferase 1, and sterol regulatory element-binding protein 1) were significantly decreased in hepatocytes by PX $150{\mu}g/ml$ treatment compared with the control (p < 0.05). In differentiated 3T3-L1 adipocytes, the lipid accumulation was significantly attenuated by all PX treatments (p < 0.01). Regulators of adipogenesis, including CCAAT-enhancer-binding proteins alpha, peroxisome proliferatoractivated receptor gamma, and perilipin, were decreased in PX $100{\mu}g/ml$ treatment compared with the control (p < 0.05). In conclusion, PX might have anti-obesity effects by blocking hepatic lipogenesis and by inhibiting adipogenesis in adipocytes.

Keywords

References

  1. Foss B, Dyrstad SM. 2011. Stress in obesity: cause or consequence? Med. Hypotheses 77: 7-10. https://doi.org/10.1016/j.mehy.2011.03.011
  2. Spiegelman BM, Flier JS. 2001. Obesity and the regulation of energy balance. Cell 104: 531-543. https://doi.org/10.1016/S0092-8674(01)00240-9
  3. De Vriendt T, Moreno LA, De Henauw S. 2009. Chronic stress and obesity in adolescents: scientific evidence and methodological issues for epidemiological research. Nutr. Metab. Cardiovasc. Dis. 19: 511-519. https://doi.org/10.1016/j.numecd.2009.02.009
  4. Bastien M, Poirier P, Lemieux I, Despres JP. 2014. Overview of epidemiology and contribution of obesity to cardiovascular disease. Prog. Cardiovasc. Dis. 56: 369-381. https://doi.org/10.1016/j.pcad.2013.10.016
  5. Klop B, Elte JWF, Cabezas MC. 2013. Dyslipidemia in obesity:mechanisms and potential targets. Nutrients 5: 1218-1240. https://doi.org/10.3390/nu5041218
  6. Korean Society for the Study of Obesity. 2015. Obesity in Korea. Available from http://www.kosso.or.kr/Obesity_pop.html. Accessed May 12, 2017.
  7. Korean Society of Lipidology and Atherosclerosis. 2015. Dyslipidemia face sheet in Korea. Available from http://www.lipid.or.kr/bbs/?code=fact_sheet. Accessed May 12, 2017.
  8. Wanless IR, Lentz JS. 1990. Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors. Hepatology 12: 1106-1110. https://doi.org/10.1002/hep.1840120505
  9. Tominaga K, Kurata PJH, Chen YK, Fujimoto E, Miyagawa S, Abe I, et al. 1995. Prevalence of fatty liver in Japanese children and relationship to obesity. Dig. Dis. Sci. 40: 2002-2009. https://doi.org/10.1007/BF02208670
  10. Lambert JE, Ramos-Roman MA, Browning JD, Parks EJ. 2014. Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease. Gastroenterology 146: 726-735. https://doi.org/10.1053/j.gastro.2013.11.049
  11. Large V, Peroni O, Letexier D, Ray H, Beylot M. 2004. Metabolism of lipids in human white adipocyte. Diabetes Metab. 30: 294-309. https://doi.org/10.1016/S1262-3636(07)70121-0
  12. Ahmadian M, Duncan RE, Jaworski K, Sarkadi-Nagy E, Sul HS. 2007. Triacylglycerol metabolism in adipose tissue. Future Lipidol. 2: 229-237 https://doi.org/10.2217/17460875.2.2.229
  13. Derosa G, Maffioli P. 2012. Anti-obesity drugs: a review about their effects and their safety. Expert Opin. Drug Saf. 11: 459-471. https://doi.org/10.1517/14740338.2012.675326
  14. Rodgers RJ, Tschop MH, Wilding JP. 2012. Anti-obesity drugs: past, present and future. Dis. Model. Mech. 5: 621-626. https://doi.org/10.1242/dmm.009621
  15. Sergent T, Vanderstraeten J, Winand J, Beguin P, Schneider YJ. 2012. Phenolic compounds and plant extracts as potential natural anti-obesity substances. Food Chem. 135: 68-73. https://doi.org/10.1016/j.foodchem.2012.04.074
  16. Maimoona A, Naeem I, Saddiqe Z, Jameel K. 2011. A review on biological, nutraceutical and clinical aspects of French maritime pine bark extract. J. Ethnopharmacol. 133: 261-277. https://doi.org/10.1016/j.jep.2010.10.041
  17. Grimm T, Schafer A, Hogger P. 2004. Antioxidant activity and inhibition of matrix metalloproteinases by metabolites of maritime pine bark extract (Pycnogenol). Free Radic. Biol. Med. 36: 811-822. https://doi.org/10.1016/j.freeradbiomed.2003.12.017
  18. Lee OH, Seo MJ, Choi HS, Lee BY. 2012. Pycnogenol inhibits lipid accumulation in 3T3-L1 adipocytes with the modulation of reactive oxygen species (ROS) production associated with antioxidant enzyme responses. Phytother. Res. 26: 403-411.
  19. Ahn HM, Go GW. 2017. Pinus densiflora bark extract (PineXol) decreases adiposity in mice by down-regulation of hepatic de novo lipogenesis and adipogenesis in white adipose tissue. J. Microbiol. Biotechnol. 27: 660-667. https://doi.org/10.4014/jmb.1612.12037
  20. Canali R, Comitato R, Schonlau F, Virgili F. 2009. The antiinflammatory pharmacology of Pycnogenol in humans involves COX-2 and 5-LOX mRNA expression in leukocytes. Int. Immunopharmacol. 9: 1145-1149. https://doi.org/10.1016/j.intimp.2009.06.001
  21. Bayeta E, Lau BH. 2000. Pycnogenol inhibits generation of inflammatory mediators in macrophages. Nutr. Res. 20: 249-259. https://doi.org/10.1016/S0271-5317(99)00157-8
  22. Packer L, Rimbach G, Virgili F. 1999. Antioxidant activity and biologic properties of a procyanidin-rich extract from pine (Pinus maritima) bark, Pycnogenol. Free Radic. Biol. Med. 27: 704-724. https://doi.org/10.1016/S0891-5849(99)00090-8
  23. Virgili F, Kobuchi H, Packer L. 1998. Procyanidins extracted from Pinus maritima (Pycnogenol): scavengers of free radical species and modulators of nitrogen monoxide metabolism in activated murine RAW 264.7 macrophages. Free Radic. Biol. Med. 24: 1120-1129. https://doi.org/10.1016/S0891-5849(97)00430-9
  24. Nocun M, Ulicna O, Muchova J, Durackova Z, Watala C. 2008. French maritime pine bark extract (Pycnogenol) reduces thromboxane generation in blood from diabetic male rats. Biomed. Pharmacother. 62: 168-172. https://doi.org/10.1016/j.biopha.2007.07.002
  25. Hasegawa N. 1999. Stimulation of lipolysis by Pycnogenol. Phytother. Res. 13: 619-620. https://doi.org/10.1002/(SICI)1099-1573(199911)13:7<619::AID-PTR498>3.0.CO;2-B
  26. Hasegawa N. 2000. Inhibition of lipogenesis by Pycnogenol. Phytother. Res. 14: 472-473. https://doi.org/10.1002/1099-1573(200009)14:6<472::AID-PTR649>3.0.CO;2-S
  27. Ho JN, Kim OK, Nam DE, Jun W, Lee J. 2014. Pycnogenol supplementation promotes lipolysis via activation of cAMPdependent PKA in ob/ob mice and primary-cultured adipocytes. J. Nutr. Sci. Vitaminol. 60: 429-435. https://doi.org/10.3177/jnsv.60.429
  28. Kim KD, Kim HJ, Park KR, Kim SM, Na YC, Shim BS, et al. 2011. PineXol inhibits in vitro inflammatory biomarkers by blocking NF-${\kappa}B$ signaling pathway and protects mice from lethal endotoxemia. Orient. Pharm. Exp. Med. 11: 61-70. https://doi.org/10.1007/s13596-011-0003-9
  29. Lee YJ, Han OT, Choi HS, Lee BY, Chung HJ, Lee OH. 2013. Antioxidant and anti-adipogenic effects of PineXol. Korean J. Food Sci. Technol. 45: 97-103. https://doi.org/10.9721/KJFST.2013.45.1.97
  30. Saliou C, Rimbach G, Moini H, McLaughlin L, Hosseini S, Lee J, et al. 2001. Solar ultraviolet-induced erythema in human skin and nuclear factor-kappa-B-dependent gene expression in keratinocytes are modulated by a French maritime pine bark extract. Free Radic. Biol. Med. 30: 154-160. https://doi.org/10.1016/S0891-5849(00)00445-7
  31. Hwang YJ. 2016. Quantitative analysis of taxifolin, (+)-catechin and procyanidin B1 from the preparation of Pinus densiflora (PineXol). Korean J. Pharmacogn. 47: 246-250.
  32. Guerrero L, Margalef M, Pons Z, Quinones M, Arola L, Arola-Arnal A, et al. 2013. Serum metabolites of proanthocyanidinadministered rats decrease lipid synthesis in HepG2 cells. J. Nutr. Biochem. 24: 2092-2099. https://doi.org/10.1016/j.jnutbio.2013.08.001
  33. Fan B, Ikuyama S, Gu JQ, Wei P, Oyama JI, Inoguchi T, et al. 2009. Oleic acid-induced ADRP expression requires both AP-1 and PPAR response elements, and is reduced by Pycnogenol through mRNA degradation in NMuLi liver cells. Am. J. Physiol. Endocrinol. Metab. 297: E112-E123. https://doi.org/10.1152/ajpendo.00119.2009
  34. Hwang YJ, Wi HR, Kim HR, Park KW, Hwang KA. 2014. Pinus densiflora Sieb. et Zucc. alleviates lipogenesis and oxidative stress during oleic acid-induced steatosis in HepG2 cells. Nutrients 6: 2956-2972 https://doi.org/10.3390/nu6072956
  35. Yang J, Jang JY, Nam DE, Lee J, Hwang KT, Jun WJ, et al. 2010. Pycnogenol inhibits adipogenesis and simulate antilipogenic effect in 3T3-L1 adipocytes. FASEB J. 24: lb254.